Low serum ferroxidase i activity is associated with mortality in heart failure and related to both peroxynitrite-induced cysteine oxidation and tyrosine nitration of ceruloplasmin

Circulation Research

Volumn 114, Issue 11, 2014, Pages 1723-1732

  Cabassi, Aderville ^a   Binno, Simone Maurizio ^a   Tedeschi, Stefano ^a   Ruzicka, Valerie ^a   Dancelli, Simona ^a   Rocco, Rossana ^a   Vicini, Vanni ^b   Coghi, Pietro ^a   Regolisti, Giuseppe ^a   Montanari, Alberto ^a   Fiaccadori, Enrico ^a   Govoni, Paolo ^a   Piepoli, Massimo ^c   De Champlain, Jacques ^d  

^a UNIVERSITY OF PARMA MEDICAL SCHOOL   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

^c Guglielmo da Saliceto Polichirurgico Hospital   (Italy)

^d CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

ceruloplasmin; heart failure; mortality; oxidative stress

Indexed keywords

3 NITROTYROSINE; ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CERULOPLASMIN; CERULOPLASMIN I; COPPER; CYSTEINE; DIGOXIN; DIMETHYL SULFOXIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; EPICATECHIN; GLUTATHIONE; HEMOGLOBIN; MALONALDEHYDE; NORADRENALIN; PEROXYNITRITE; SODIUM; THIOL; TUMOR NECROSIS FACTOR ALPHA; TYROSINE; UNCLASSIFIED DRUG;

AGE; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR MORTALITY; CELLULAR PARAMETERS; CERULOPLASMIN BLOOD LEVEL; CONTROLLED STUDY; COPPER BLOOD LEVEL; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; GENDER; GLOMERULUS FILTRATION RATE; HEART EJECTION FRACTION; HEART FAILURE; HEART RATE; HOSPITALIZATION; HUMAN; HYPERTENSION; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MAJOR CLINICAL STUDY; MALE; NEW YORK HEART ASSOCIATION CLASS; NITRATION; NORADRENALIN BLOOD LEVEL; OXIDATION; PREDICTOR VARIABLE; PRIORITY JOURNAL; RED CELL DISTRIBUTION WIDTH; SMOKING HABIT; SODIUM BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; WESTERN BLOTTING;

CERULOPLASMIN; HEART FAILURE; MORTALITY; OXIDATIVE STRESS;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CERULOPLASMIN; COHORT STUDIES; CYSTEINE; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; MALE; NATRIURETIC PEPTIDE, BRAIN; NOREPINEPHRINE; OXIDATION-REDUCTION; PEROXYNITROUS ACID; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SURVIVAL RATE; TYROSINE;

EID: 84901621405     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.114.302849     Document Type: Article

References (30)

1. Hare JM, Stamler JS. NO/redox disequilibrium in the failing heart and cardiovascular system. J Clin Invest. 2005;115:509-517.
2. McMurray J, Chopra M, Abdullah I, Smith WE, Dargie HJ. Evidence of oxidative stress in chronic heart failure in humans. Eur Heart J. 1993;14:1493-1498.
3. Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev. 2007;87:315-424.
4. Gutteridge JM. Antioxidant properties of caeruloplasmin towards iron-and copper-dependent oxygen radical formation. FEBS Lett. 1983;157:37-40.
5. Mukhopadhyay CK, Attieh ZK, Fox PL. Role of ceruloplasmin in cellular iron uptake. Science 1998;279:714-717.
6. Eiserich JP, Hristova M, Cross CE, Jones AD, Freeman BA, Halliwell B, van der Vliet A. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature. 1998;391:393-397.
7. Chahine R, Mateescu MA, Roger S, Yamaguchi N, de Champlain J, Nadeau R. Protective effects of ceruloplasmin against electrolysis-induced oxygen free radicals in rat heart. Can J Physiol Pharmacol. 1991;69:1459-1464.
8. Tang WH, Wu Y, Hartiala J, Fan Y, Stewart AF, Roberts R, McPherson R, Fox PL, Allayee H, Hazen SL. Clinical and genetic association of serum ceruloplasmin with cardiovascular risk. Arterioscler Thromb Vasc Biol. 2012;32:516-522.
9. Dadu RT, Dodge R, Nambi V, Virani SS, Hoogeveen RC, Smith NL, Chen F, Pankow JS, Guild C, Tang WH, Boerwinkle E, Hazen SL, Ballantyne CM. Ceruloplasmin and heart failure in the Atherosclerosis Risk in Communities study. Circ Heart Fail. 2013;6:936-943.
10. Klipstein-Grobusch K, Grobbee DE, Koster JF, Lindemans J, Boeing H, Hofman A, Witteman JC. Serum caeruloplasmin as a coronary risk factor in the elderly: the Rotterdam Study. Br J Nutr. 1999;81:139-144.
11. Pacher P, Schulz R, Liaudet L, Szabó C. Nitrosative stress and pharmacological modulation of heart failure. Trends Pharmacol Sci. 2005;26:302-310.
12. Ferdinandy P, Danial H, Ambrus I, Rothery RA, Schulz R. Peroxynitrite is a major contributor to cytokine-induced myocardial contractile failure. Circ Res. 2000;87:241-247.
13. Gole MD, Souza JM, Choi I, Hertkorn C, Malcolm S, Foust RF 3rd, Finkel B, Lanken PN, Ischiropoulos H. Plasma proteins modified by tyrosine nitration in acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol. 2000;278:L961-L967.
14. Radi R, Beckman JS, Bush KM, Freeman BA. Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. J Biol Chem. 1991;266:4244-4250.
15. Landino LM, Skreslet TE, Alston JA. Cysteine oxidation of tau and microtubule-associated protein-2 by peroxynitrite: modulation of microtubule assembly kinetics by the thioredoxin reductase system. J Biol Chem. 2004;279:35101-35105.
16. Mitrogianni Z, Barbouti A, Galaris D, Siamopoulos KC. Tyrosine nitration in plasma proteins from patients undergoing hemodialysis. Am J Kidney Dis. 2004;44:286-292.
17. Swedberg K, Cleland J, Dargie H, et al; Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J. 2005;26:1115-1140.
18. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW; American College of Cardiology Foundation; American Heart Association. Focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. Circulation 2009;119:e391-479.
19. Smilde TD, van Veldhuisen DJ, Navis G, Voors AA, Hillege HL. Drawbacks and prognostic value of formulas estimating renal function in patients with chronic heart failure and systolic dysfunction. Circulation 2006;114:1572-1580.
20. Erel O. Automated measurement of serum ferroxidase activity. Clin Chem. 1998;44:2313-2319.
21. Cabassi A, Vinci S, Quartieri F, Moschini L, Borghetti A. Norepinephrine reuptake is impaired in skeletal muscle of hypertensive rats in vivo. Hypertension 2001;37:698-702.
22. Cabassi A, de Champlain J, Maggiore U, et al. Prealbumin improves death risk prediction of BNP-added Seattle Heart Failure Model: results from a pilot study in elderly chronic heart failure patients. Int J Cardiol. 2013;168:3334-3339.
23. Cabassi A, Dumont EC, Girouard H, Bouchard JF, Le Jossec M, Lamontagne D, Besner JG, de Champlain J. Effects of chronic N-acetylcysteine treatment on the actions of peroxynitrite on aortic vascular reactivity in hypertensive rats. J Hypertens. 2001;19:1233-1244.
24. Schroeder P, Klotz LO, Buchczyk DP, Sadik CD, Schewe T, Sies H. Epicatechin selectively prevents nitration but not oxidation reactions of peroxynitrite. Biochem Biophys Res Commun. 2001;285:782-787.
25. Cabassi A, Dancelli S, Pattoneri P, et al. Characterization of myocardial hypertrophy in prehypertensive spontaneously hypertensive rats: interaction between adrenergic and nitrosative pathways. J Hypertens. 2007;25:1719-1730.
26. Reifenberger MS, Arnett KL, Gatto C, Milanick MA. The reactive nitrogen species peroxynitrite is a potent inhibitor of renal Na-K-ATPase activity. Am J Physiol Renal Physiol. 2008;295:F1191-F1198.
27. Lokuta AJ, Maertz NA, Meethal SV, Potter KT, Kamp TJ, Valdivia HH, Haworth RA. Increased nitration of sarcoplasmic reticulum Ca2+-ATPase in human heart failure. Circulation 2005;111:988-995.
28. Eleuteri E, Di Stefano A, Ricciardolo FL, Magno F, Gnemmi I, Colombo M, Anzalone R, Cappello F, La Rocca G, Tarro Genta F, Zummo G, Giannuzzi P. Increased nitrotyrosine plasma levels in relation to systemic markers of inflammation and myeloperoxidase in chronic heart failure. Int J Cardiol. 2009;135:386-390.
29. Lancel S, Qin F, Lennon SL, Zhang J, Tong X, Mazzini MJ, Kang YJ, Siwik DA, Cohen RA, Colucci WS. Oxidative posttranslational modifications mediate decreased SERCA activity and myocyte dysfunction in Galphaq-overexpressing mice. Circ Res. 2010;107:228-232.
30. Alvarez B, Radi R. Peroxynitrite reactivity with amino acids and proteins. Amino Acids. 2003;25:295-311.